Table 3.
Index | NFL VIPsa | t-TAU VIPsa |
---|---|---|
Sex | 0.01 | 1.83 |
Age | 2.74 | 0.18 |
t-TAU | 1.53 | |
NFL | 0.82 | |
Amyloid PET SUVR | 0.69 | 0.08 |
APOE ɛ4 | 0.14 | 0.53 |
Cognitive score | ||
MMSE | 1.47 | 0.72 |
FCSRT | 0.94 | 0.62 |
Clinical characteristics | ||
AF | 0.77 | 0.29 |
BMI | 1.25 | 0.81 |
Diabetes | 0.38 | 0.56 |
Dyslipidemia | 0.06 | 0.34 |
Head trauma | 0.20 | 0.53 |
HTA | 1.27 | 0.22 |
IHD | 1.21 | 0.47 |
Mood Disorders | 0.01 | 1.19 |
OSAS | 0.80 | 1.04 |
Plasma Vit. B12 deficiency | 0.01 | 2.48 |
AF atrial fibrillation, BMI body mass index, FCSRT free and cued selective reminding test, HTA arterial hypertension, IHD ischemic heart disease, MMSE Mini-Mental State Examination, NFL neurofilament light chain, OSAS obstructive sleep apnea syndrome, SD standard deviation, SMC subjective memory complaints, SUVR standardized uptake value ratio, t-Tau total Tau, VIPs variable importance for the projection
aVIPs is considered significant when ≥ 1.5